The U.K. government placed its centerpiece vaccine manufacturing facility near Oxford on the auction block in a bid to recoup about 215 million pounds ($287 million) it had invested in the site, the Financial Times reports. The facility has already attracted several offers, according to the newspaper. Interested bidders include Oxford BioMedica, Swiss CDMO giant Lonza and Japan’s Fujifilm, the FT's sources said. Source: FiercePharma 29/11/2021